An Investigation of Factors Contributing to Higher Levels of Placebo Response in Clinical Trials in Neuropathic Pain: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

An Investigation of Factors Contributing to Higher Levels of Placebo Response in Clinical Trials in Neuropathic Pain: A Systematic Review and Meta-Analysis

Published:2015-01-06 Issue:2 Volume:35 Page:67-81
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Arakawa Akio,Kaneko Masayuki,Narukawa Mamoru

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-014-0259-1.pdf

Reference98 articles.

1. European Medical Agency. Guideline on clinical medical products intended for the treatment of neuropathic pain. 2007. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000425.jsp&mid=WC0b01ac0580034cf5 . Accessed 22 Aug 2014.

2. U.S. Food and Drug Administration. Guidance for Industry–Analgesic Indications: Developing Drug and Biological Products [Draft guidance]. February 2014. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm . Accessed 22 Aug 2014.

3. Dworkin RH, Turk DC, Peirce-Sandner S, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 2010;149:177–93.

4. Dworkin RH, Turk DC, Peirce-Sandner S, et al. Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database. Pain. 2010;150:12–6.

5. Cepeda MS, Berlin JA, Gao CY, et al. Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis. Pain Med. 2012;13:575–95.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choice Enhances Placebo Hypoalgesia More in Weaker Placebo Contexts: A Partial Reinforcement Study;The Journal of Pain;2024-01

2. Sham controls in device trials for chronic pain – tricky in practice-a review article;Contemporary Clinical Trials Communications;2023-10

3. Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis;Pain;2023-08-02

4. How familiar are German dermatologists with placebo and nocebo effects and to what extent are these targeted in clinical practice: A survey within the dermatological community;Journal of the European Academy of Dermatology and Venereology;2023-06-26

5. What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update;Pain;2023-06-07